• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DON
Click for more information
0.00% 4.5¢

DIAMONEX LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DON
Ann: Ceasing to be a substantial holder - J.P. Mo 		03/07/13 0 894
03/07/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  894 
DON
Ann: Change in substantial holding - J.P. Morgan 		03/07/13 0 879
03/07/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  879 
DON
Ann: Annual Report to shareholders 2011 		27/06/13 0 898
Metals & Mining SECTOR NEWS

Dive into Bécancour: watch the latest project updates from Lithium Universe

Read More   right-arrow Created with Sketch.
LU7
04 Oct 2024
LITHIUM UNIVERSE LIMITED
27/06/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  898 
DON
Ann: Appendix 3B 		27/06/13 0 815
27/06/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  815 
DON
Ann: Appendix 3B 		27/06/13 0 786
27/06/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  786 
DON
Ann: Appendix 3B 		27/06/13 0 780
27/06/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  780 
DON
Ann: Half Yearly Report and Accounts 		13/05/13 0 540
13/05/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  540 
DON
Ann: Quarterly Activities Report 		30/04/13 0 676
30/04/13 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  676 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
NEWS New multi-lode gold shoot discovery boosts development potential—find out who's behind this
right-arrow Created with Sketch.
AHK New MRE update reveals significant resource uplift at Sandy Mitchell—discover the details
right-arrow Created with Sketch.

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation After just over a week, the thrill China’s latest stimulus announcements put into world markets has started to subside.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Neurotech knocked back by FDA as agency declares target condition not rare enough for special status Neurotech International (NTI) has flagged to its shareholders that the FDA hasn't granted its product NTI164 orphan drug status.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.

Featured News

NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
CC9 Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
NEWS Regulatory approval granted for drilling at high-grade lead and silver project—drilling set to begin soon
right-arrow Created with Sketch.
AHK New MRE update reveals significant resource uplift at Sandy Mitchell—discover the details
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.